With a global increase in clinical depression caused by the ongoing pandemic, more and more folks are turning to prescription therapeutics. For many, Psilocybin, MDNA and the like have become the most preferred therapeutics since Prozac. Growing evidence indicates that both are effective at reducing symptoms of depression as conventional treatment.
In fact, researchers have found that psychedelics like psilocybin, LSD, DMT and many others may be more effective than conventional medicine in treating mental health issues like depression, PTSD, dementia and many others. As this emerging industry is estimated to be worth USD $ 6.85 billion by 2027 – what are the top 3 psychedelic stocks to buy now?
With so much promise and growth potential, it’s difficult to know exactly where to invest for both short-term and long-term profits. However, cannin.com has curated a list of the top 3 psychedelic stocks to buy.
What are the Top 3 Psychedelic Stocks to Buy Now?
1. Compass Pathways PLC (NASDAQ: CMPS)
[stock_market_widget type=”combo” symbol=”CMPS” template=”tablechart” color=”default” fields=”virtual.symbol,virtual.name,quote.regularMarketPrice,quote.regularMarketChange,quote.regularMarketChangePercent” chart=”line” range=”1y” interval=”1d” line-color=”rgb(31, 122, 9)”]
Mental health care company Compass Pathways is dedicated to accelerating patient access to evidence-based innovation in mental health. Back in October 2020, the company had a successful IPO in which it raised USD $146 million on the Nasdaq. Compass has received two US patents for its psilocybin therapies.
Related: Psychedelic Patents – The Race is On
Their focus is on providing effective alternative psychedelic therapies for those dealing with mental health issues but aren’t helped by conventional treatments. COMPASS is currently developing a psilocybin therapy, COMP360, which aimed at treating patients with Treatment-Resistant Depression (TRD). As this psychedelic stock is currently trading at half it’s median price target of $70.50/share, Compass Pathways is certainly one of the top 3 psychedelic stocks to buy now.
2. Field Trip Health Limited (OTC: FTRP)
[stock_market_widget type=”combo” symbol=”FTRPF” template=”tablechart” color=”default” fields=”virtual.symbol,virtual.name,quote.regularMarketPrice,quote.regularMarketChange,quote.regularMarketChangePercent” chart=”line” range=”1y” interval=”1d” line-color=”rgb(31, 122, 9)”]
Field Trip Health makes the list as one of best psychedelic stocks to buy now as the company is leveraging cutting-edge therapies to change how depression is treated. In fact, the company has pioneered a revolutionary ketamine-enhanced psychotherapy to help treat maladies like anxiety, pain and depression. This revolutionary approach has helped Field Trip Health open five locations in the United States as well as Canada and Amsterdam.
Related: Why Psychedelics are Vital to the Future of Mental Health
This psychedelic stock is listed on the Canadian Securities Exchange, trading with the ticker symbol ‘FTRP.’ As revenues are projected to increase by a whopping 519% over the next five years, investing $100 in FTRP today may end up having a six fold increase by 2026.
3. MindMeld (OTC: MNMD)
[stock_market_widget type=”combo” symbol=”MNMD” template=”tablechart” color=”default” fields=”virtual.symbol,virtual.name,quote.regularMarketPrice,quote.regularMarketChange,quote.regularMarketChangePercent” chart=”line” range=”1y” interval=”1d” line-color=”rgb(31, 122, 9)”]
Rounding out our top 3 psychedelic stocks to buy now is MindMeld. This stock is an interesting play as the company is choosing to build its asset portfolio in order to reduce leverage and exposure. Risk-averse options investors should pay extra attention to this investment opportunity.
Related: The Legalization of Psychedelics – How far has it Come?
The company continues to conduct clinical trials of medicines based on psychedelics. MindMeld intends to grow its pipeline through acquisitions, joint-Ventures, and collaborative development agreements. As this stock is less riskier than others, MindMed is certainly one of the top 3 psychedelic stocks to buy now.
What are the Top 3 Psychedelic Stocks to Buy Now?
About Cannin Investment Group: Your Psychedelic Stocks Resource
Cannin is your trusted resource for psychedelic stocks. Our global team of experts evaluates all emerging psychedelic stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best psychedelic stock investments for 2021.
Is it too late to invest in psychedelic stocks? No! This is the perfect time to invest.
Are you looking to buy stock in the best psychedelic companies for 2021? Interested in emerging penny psychedelic stocks?
If so, are you interested in psychedelic stocks like MindMed, Compass Pathways or Revive Therapeutics?
Predict price movements of stocks several hours in advance with our proprietary algorithmic stock trading software.
- +30% Gains in 2020
- +49.8% Gains in 2019
- 108% Backtested since 2012
We’re so confident you’ll love our algotrading pot stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best psychedelic stocks – we’ll show you how at cannin.com.
